EDGAR Filing Documents for 0001193125-09-250387

Form 8-K - Current report:

SEC Accession No. 0001193125-09-250387

Filing Date

2009-12-10

Accepted

2009-12-10 09:26:26

Documents

Period of Report

2009-12-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	25963
2	PLACEMENT AGENT AGREEMENT	dex11.htm	EX-1.1	85422
3	FORM OF COMMON STOCK PURCHASE WARRANT	dex41.htm	EX-4.1	70777
4	OPINION OF PILLSBURY WINTHROP SHAW PITTMAN LLP	dex51.htm	EX-5.1	7973
5	FORM OF SECURITIES PURCHASE AGREEMENT	dex101.htm	EX-10.1	151724
6	PRESS RELEASE	dex991.htm	EX-99.1	10072
7	RISK FACTORS	dex992.htm	EX-99.2	113443
8	GRAPHIC	g10230ex11p1.jpg	GRAPHIC	5189
9	GRAPHIC	g10230ex51p1.jpg	GRAPHIC	1449
10	GRAPHIC	g10230ex991p1.jpg	GRAPHIC	4193
	Complete submission text file	0001193125-09-250387.txt		482606

Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381

Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331

Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)